FDA Reform Bill, Google & More!: What We’re Talking About This Week

1.  4 things you need to know about the sweeping FDA reform bill Congress proposed last night  A very important healthcare reform bill was passed by Congress and this article tells you everything you need to know about it! 2.  Stanford scientists use modified RNA to rejuvenate aging cells  Stanford scientists have found a way […]

Diabetes, Advantages of Alcohol & More!: What We’re Talking About This Week

This week we are talking about lowering Diabetes in minority women, the advantages of the moderate use of alcohol, and the effects of pricing from small CRO consolidation. 1. Healthy Diet Lowers Risks For Type 2 Diabetes In Minority Women We talk a lot about the importance of diversity in clinical trials, this article shows results that is great […]

ePRO, CROs & More!: What We’re Talking About This Week

Lots to talk about this week, we’ve narrowed it down to ePRO, CRO’s, Clinical Trial Enrollment and new details about hospital infection rates. 1.  CROs plan to increase use of ePRO tech CROs, as well as sponsors, are receptive to, and plan to increase their use of ePRO (electronic patient reported outcomes), according to a survey published […]

CTMS, Diversity, & India: What We’re Talking About This Week

Now that we are back from a fantastic break, we hope you will start the New Year off with a quick read of this week’s hot topics! 1. Incorporating eTMF Functionality Into CTMS  Clinplus’s Bob Borysko discusses the many aspects of a great CTMS. 2. ‘I’m In’ Campaign and FDA Recommendations  Look to Boost Diversity in Clinical Testing  […]